Skip to main content
Clinical Trials/ACTRN12614000047695
ACTRN12614000047695
Completed
未知

A study investigating age and sex specific reference ranges for periostin in a general adult population without asthma or any other significant respiratory co-morbidity

Medical Research Institute of New Zealand0 sites500 target enrollmentJanuary 17, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Periostin levels
Sponsor
Medical Research Institute of New Zealand
Enrollment
500
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged between 18 to 75 years
  • Able to provide written informed consent

Exclusion Criteria

  • Doctor’s diagnosis of Asthma, Bronchitis or COPD
  • Wheezing or use of respiratory inhalers in the past 12 months
  • Known pregnancy
  • Significant co morbidities (determined at investigator discretion)
  • Hospital admission within last 3 months
  • Surgery within last 3 months, determined at investigator discretion (this includes all major surgery requiring general anaesthetic, dental extractions and root canal procedures. This does not include minor procedures, including but not limited to mole or wart removal, dental fillings etc).
  • Bone fracture within the last 3 months
  • Systemic Corticosteroids within the last 3 months
  • Active (current, or within the 3 weeks prior to the visit) upper or lower respiratory tract infection
  • Any other safety concern at the investigator’s discretion

Outcomes

Primary Outcomes

Not specified

Similar Trials